| Time of assessment | |||||
---|---|---|---|---|---|---|
 | Inclusion | 3 W | 8 W | 16 W | 24 W | 1 YR |
Screening for inclusion | X | Â | Â | Â | Â | Â |
Demographics, cancer history, planned RT, previous pain therapy | X | Â | Â | Â | Â | Â |
New cancer related incidents | Â | X | X | X | X | X |
Current use of medications | X | X | X | X | X | X |
Weight | X | X | X | X | X | X |
Performance status | X | X | X | X | X | X |
CT scans for body composition (if available) | X | X | X | X | X | X |
PG-SGA | X | X | X | X | X | X |
Pain registrations | X | X | X | X | X | X |
QLQ-C15 PAL | X | X | X | X | X | X |
LANSS | X | X | X | Â | Â | Â |
Episodic pain questions | X | X | X | Â | Â | Â |
PHQ9 | X | X | X | X | X | X |
Blood samples for clinical chemistry | X | X | X | X | X | X |
Blood samples for biomarkers | X | X | X | X | X | X |
Blood samples for genetics | X | Â | Â | Â | Â | Â |